🔎 Trials Near Me

Beranda › Diabetes Tipe 1 › Illinois

Uji klinis Diabetes Tipe 1 di Illinois

16 studi untuk Diabetes Tipe 1 mencari peserta di lokasi di Illinois.

Kota di Illinois

Teks studi resmi (Bahasa Inggris)

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

  • Ann & Robert H. Lurie Children's Hospital, Chicago
  • Northwestern University, Chicago
  • Southern Illinois University School of Medicine, Springfield
Menerima pesertaFase 1/2
Usia 12 hingga 35 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06783309

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

  • University of Chicago, Chicago
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 1 Sep 2026 · NCT04786262

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

  • University of Illinois Hospital & Health Sciences System, Chicago
Menerima pesertaFase 1/2
Usia 35 hingga 70 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06575426

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Northwestern University, Chicago
Menerima peserta
Usia 14 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07579702

Circadian Mechanisms, Glucose, and CV Risks in T1D

  • University of Illinois Chicago, Chicago
Menerima peserta
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06624046

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

  • Northwestern University, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT07676565

Mathematical Modeling of Blood Sugar and Hormone Responses in Insulin-Dependent Type 2 Diabetes

  • Illinois Institute of Technology, Chicago
Menerima pesertaStudi observasional
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT07650682

A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers

  • Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Menerima peserta
Usia 14 hingga 18 · Semua jenis kelamin · Diperbarui 29 Mei 2026 · NCT06709755

Kidney Precision Medicine Project

  • University of Illinois Chicago, Chicago
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT04334707

Registry for Stage 2 Type 1 Diabetes

  • University of Chicago Medical Center- Site Number : 8400017, Chicago
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06481904

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

  • University of Chicago Medical Center, Chicago
Menerima pesertaFase 2
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT06964087

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • Northwestern University Feinberg School of Medicine, Chicago
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 24 Mar 2026 · NCT06217302

CBTi for the Treatment of Insomnia in Type 1 Diabetes

  • University of Illinois Chicago, Chicago
Menerima pesertaFase awal 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT07091318

Type 1 Diabetes and Obstructive Sleep Apnea

  • University of Chicago, Chicago
Menerima peserta
Usia 18 hingga 50 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06915831

Islet Transplantation in Patients With "Brittle" Type I Diabetes

  • University of Chicago Medical Center, Chicago
Menerima peserta
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Des 2025 · NCT01630850

Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • The University of Chicago, Chicago
Menerima pesertaFase 2
Usia 18 hingga 68 · Semua jenis kelamin · Diperbarui 8 Des 2025 · NCT01241864

Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.